Clin2
NCT07619001Possibly a fitNot yet recruiting

Testing a New Cancer Drug in Healthy Chinese Men

Healthy Male Adults Participants

Treatments studied

This study tests how a new drug called AK104 works in the body by measuring how it moves through the bloodstream. Researchers are looking for healthy men to help understand if this drug is safe and how it behaves, which could eventually help cancer patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
158 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are a healthy male aged 18–45 years
  • Your weight is between 121–165 pounds and your BMI (body size) is between 19–26
  • You have no serious medical conditions (heart, lung, kidney, diabetes, autoimmune disease, or cancer history)
  • You are willing to use birth control for 6 months after the study and not donate sperm
  • You can attend all study visits and have blood tests done regularly

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06947109Not yet recruiting· Phase 1
Study of AK139 in healthy volunteers

This trial tests a new medicine called AK139 in healthy people to see how safe it is and how the body processes it. It is for healthy adults aged 18 to 55.

Hangzhou, Zhejiang
NCT05142423Recruiting· Phase 1/Phase 2
First study of AK109 plus AK104 for advanced solid cancers

This Phase 1/2 trial tests a combination of two immune-targeting drugs (AK109 and AK104) in people with advanced solid tumors that can’t be treated with standard options, or where standard treatment didn’t work or wasn’t tolerated. It aims to find safe dosing and whether the treatment can shrink tumors or control the disease.

Hangzhou, Zhejiang
NCT05868876Recruiting· Phase 1
Testing AK127 plus AK104 for advanced cancers

This Phase 1 study tests the safety and early anti-cancer activity of AK127 given together with AK104 in people with advanced solid tumors. You may be considered if standard treatments have already been tried or aren’t suitable for you.

Tianjin, Tianjin Municipality
NCT06996704Recruiting· Phase 1
Study of AK0610 in healthy adults

This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.

Jinan, Shandong
NCT07432698Not yet recruiting· Phase 1
Testing AK0406 injection safety in healthy volunteers

This study tests the safety and how the body processes a new drug called AK0406 in healthy adults. If you are generally healthy and match the age and weight requirements, you may be able to help researchers understand if the drug is safe before it is tested in people with a medical condition.

Bayswater, Victoria
NCT07046559Recruiting· Phase 1
Testing a new drug's safety in healthy volunteers

This trial is testing an experimental drug called LY4066708 in healthy people to see how safe it is and how the body processes it. It may help researchers understand if the drug can be used in future studies for conditions like Alzheimer's disease.

Holbeck, Leeds

Hear when a new Healthy Male Adults Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.